Effects of sacubitril-valsartan on clinical, echocardiographic and polygraphic parameters in patients affected by heart failure with reduced ejection fraction and sleep apnea

29 August 2022 (15:30 - 15:40)
Organised by:
Congress Presentation Part of: Neprilysin inhibition: news and nuggets Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Professional Premium Access ESC Congress 2022

ESC 365 is supported by

ESC 365 is supported by